The rise in prevalence of target diseases and rising demand for cancer therapeutics worldwide are boosting the global nuclear medicine market predicts Fortune Business Insights in their recent study. The study is titled “Nuclear Medicine Market Size, Share and Global Trend By Type (Diagnostic, Therapeutics), By Application (Cancer, Cardiovascular diseases, Neurological disorder, Gastrointestinal diseases, Others), By End User (Diagnostic laboratories, Hospitals, Ambulatory services, Others) and Geography Forecast till 2026,” and it covers several important aspects related to the market including drivers, restraints, trends and opportunities, and offers insights into key strategies adopted by market vendors to stay ahead in competition.
The report covers:
- Global Nuclear Medicine Market trends, with detailed analysis on consumer trends & manufacturer trends.
- Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
- Key areas of investments identifying market opportunities and challenges in forecast timeframe.
- Competitive analysis of the industry players along with the overview on strategic management.
- Comprehensive company profiles of the major industry players.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nuclear-medicine-market-101027
Leading Players operating in the Nuclear Medicine Market are:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- General Electric Company
- Mallinckrodt plc
- Eckert & Ziegler Strahlen- und Medizintechnik AG
- Teva Pharmaceutical Industries Ltd
- Jubilant Life Sciences Ltd.
Rise in Prevalence of Cancer Worldwide to Promote Growth of Radiopharmaceuticals
One of the major factors propelling the global nuclear medicine market growth is the rising prevalence of various types of cancer worldwide. The World Health Organization states that cancer ranks second in terms of deaths worldwide, and accounted for about 8.8million deaths in 2015. This rise has a direct impact on the use of nuclear medicines or radiopharmaceuticals and will help the market generate higher revenues in the forecast period.
Other factors promoting the enabling global nuclear medicine market growth is advancement in treatment monitoring, and wide adoption of Position Emission Tomography (PET) tools for medication. They are gaining much more traction in the market owing to the fact that PET tools has higher precision over other treatment procedures.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/nuclear-medicine-market-101027
Rise in Awareness about Cancer Therapeutics in Developing Nations to Enable Growth in Asia Pacific
Fortune Business Insights foresees Europe and North America to hold highest percentage of the overall the global nuclear medicine market share. This is attributable to the increasing use of nuclear medicines in these regions. In 2017, the National Cancer Institute has found that about 15,000 children aged below 19 years were diagnosed with cancer in the U.S.
The rising incidence of cancer in the developed regions and advancement in medical technology are boosting the market in Europe and North America. Increasing investments by companies in these regions for research and development of cancer therapeutics is further anticipated to help the regions continue its dominance in the forthcoming years.
Some of the companies operating in the global nuclear medicines market are Eckert & Ziegler Strahlen- und Medizintechnik AG, Advanced Accelerator Applications (Aaa, Acquired By Novartis), Teva Pharmaceutical Industries Ltd, Eczacibasi-Monrol Nuclear Products, Lantheus Medical Imaging, Mallinckrodt plc., Jubilant Life Sciences Ltd., Cardinal Health, General Electric Company, and others.
- Extensive product offerings
- Customer research services
- Robust research methodology
- Comprehensive reports
- Latest technological developments
- Value chain analysis
- Potential Nuclear Medicine Market opportunities
- Growth dynamics
- Quality assurance
- Post-sales support
- Regular report updates
Reasons to Purchase this Report:
- Comprehensive analysis of the Nuclear Medicine Market growth drivers, obstacles, opportunities, and other related challenges.
- Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
- Identifies market restraints and boosters.
- Identifies all the possible segments present in the market to aid organizations in strategic business planning.
More Trending Topics from Fortune Business Insights:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245